Skip to main content
. 2023 Oct 28;14(3):1317–1328. doi: 10.1016/j.apsb.2023.10.018

Figure 7.

Figure 7

Analytical process for non-Hodgkin's lymphoma patient serum and example data of identified and confirmed peptides using ZenoTOFTM 7600 system. (a) XICs of peptides containing N319/D319 and M256/M256 oxidated. (b) Comparison of the isotopic distributions of the triply/doubly charged ions for the native and modified peptides. (c) Representative fragment ions detected in the MS/MS spectrum.